Aug 7 (Reuters) - Kazia Therapeutics Ltd (KZA) : US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA